Does Vitamin D Deficiency Contribute to COVID-19 Severity?
In this systematic review, we assessed studies that probed at vitamin D deficiencies in both positive and negative COVID-19 cases. We compared vitamin D levels to see if there was a noticeable difference. Finally, through the review of several studies, we investigated whether more severe cases of CO...
Saved in:
Published in | Current developments in nutrition Vol. 6; no. Supplement_1; p. 207 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.06.2022
Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In this systematic review, we assessed studies that probed at vitamin D deficiencies in both positive and negative COVID-19 cases. We compared vitamin D levels to see if there was a noticeable difference. Finally, through the review of several studies, we investigated whether more severe cases of COVID-19 were correlated with low vitamin D levels.
The mean and standard deviations of the vitamin D levels in patients who tested positive and negative for COVID-19 were analyzed. We used Practical Meta-Analysis Effect Size Calculator developed by David B. Wilson, Ph.D., George Mason University when looking at COVID-19 status and vitamin D (N = 50–80 nmol/L) deficient levels. In this systematic review, we measured mean, standard deviations, and 95% CI of many studies to determine if there is a consistent relationship between vitamin D levels and COVID-19. We also performed an independent sample t-test comparing non-survivors vs. survivors of COVID-19 and vitamin D levels, and when comparing moderate vs. severe COVID-19 symptoms and vitamin D levels.
A few studies were compared to evaluate the difference in vitamin D levels (serum 25(OH)D, nmol/L) among those who tested positive for COVID-19 to those who tested negative. It was found that the average median serum 25(OH)D, nmol/L for patients who tested positive was 27.08 nmol/L (±0.58 SD, 95% CI: 1.88) and the average median of serum 25(OH)D, nmol/L for patients who tested negative was 48.67 nmol/L (±13.66 SD, 95% CI: 2.17) this difference was near significant (p = .059). When looking at the relationship between vitamin D levels and severity of COVID-19 progression the result was not statistically significant, t(df) = 0.84, p = .216. When comparing the average values of vitamin D level among those who survived COVID-19 vs. those who did not, the results were not statistically significant, t(269) = 0.17, p = .438.
It is apparent that there is a trend found in relationships among those who test positive for COVID-19 and their vitamin D levels. There seems to be a correlation between vitamin D deficiency and likelihood of developing severe illness of COVID-19 when observing studies individually. However, when comparing studies on a larger scale it seems that the significant difference seems to fade.
None. |
---|---|
ISSN: | 2475-2991 2475-2991 |
DOI: | 10.1093/cdn/nzac048.021 |